HDAC inhibitors Panobinostat and Romidepsin enhance tax transcription in HTLV-1-infected cell lines and freshly isolated patients' T-cells.

MLA

Schnell, Annika P., et al. “HDAC Inhibitors Panobinostat and Romidepsin Enhance Tax Transcription in HTLV-1-Infected Cell Lines and Freshly Isolated Patients’ T-Cells.” Frontiers in Immunology, vol. 13, Aug. 2022, pp. 1–19. EBSCOhost, https://doi.org/10.3389/fimmu.2022.978800.

APA

Schnell, A. P., Kohrt, S., Aristodemou, A., Taylor, G. P., Bangham, C. R. M., & Thoma-Kress, A. K. (2022). HDAC inhibitors Panobinostat and Romidepsin enhance tax transcription in HTLV-1-infected cell lines and freshly isolated patients’ T-cells. Frontiers in Immunology, 13, 1–19. https://doi.org/10.3389/fimmu.2022.978800

Chicago

Schnell, Annika P., Stephan Kohrt, Aris Aristodemou, Graham P. Taylor, Charles R. M. Bangham, and Andrea K. Thoma-Kress. 2022. “HDAC Inhibitors Panobinostat and Romidepsin Enhance Tax Transcription in HTLV-1-Infected Cell Lines and Freshly Isolated Patients’ T-Cells.” Frontiers in Immunology 13 (August): 1–19. doi:10.3389/fimmu.2022.978800.